"This tiny company is using AI and robotics to transform biotech"
As part of the Wall Street Unplugged podcast, Frank Curzio interviewed Dr. Jason Hein on all things Telescope – what we do, why we do it, and how it’s changing the pharma world. Check out the original page at https://www.curzioresearch.com/this-tiny-company-is-using-ai-and-robotics-to-transform-biotech/
HIGHLIGHTS
- Welcome, Jason Hein, founder of Telescope Innovations (TELIF) [5:16]
- Telescope’s robotic labs are revolutionizing biotech [8:27]
- Leveraging AI to reduce costs and improve patent timelines [14:02]
- Partnerships with the biggest names in Big Pharma [16:28]
- TELIF’s management team is renowned in the scientific community [26:46]
- Why this year will be a game changer for Telescope Innovations [31:56]
TRANSCRIPT
Transcript is available at the original Curzio Research site: https://www.curzioresearch.com/this-tiny-company-is-using-ai-and-robotics-to-transform-biotech/
About Telescope Innovations
Telescope is a chemical technology company developing intelligent automation technologies and scalable manufacturing processes for the pharmaceutical and chemical industry. The Company builds and deploys reaction sampling systems for real-time analysis, flexible robotic platforms, and artificial intelligence software that improves experimental throughput, efficiency, and data quality. The Company’s “Self-Driving Labs” are fully autonomous, physical AI platforms that plan, execute, and analyze experiments far more efficiently than traditional manual approaches. Bio-pharmaceutical, high value specialty chemical, and advanced materials companies utilize Telescope’s products and services to accelerate the development and optimization of chemical processes, thereby cutting down time and costs from lab to market. For more information, please visit www.telescopeinnovations.com.
